Nucleocapsid protein function in early infection processes

Virus Research

Volumn 134, Issue 1-2, 2008, Pages 39-63

  Thomas, James A ^a   Gorelick, Robert J ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Cell culture; Core uncoating; Integration; Nucleic acid chaperone; Nucleocapsid; Reverse transcription

Indexed keywords

INTEGRASE; NUCLEIC ACID; NUCLEOCAPSID PROTEIN; PEPTIDE; SINGLE STRANDED DNA; TRANSFER RNA; VIRUS DNA; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL FREE SYSTEM; DIMERIZATION; DNA INTEGRATION; GENETIC ANALYSIS; GENOME; INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION; TRANSCRIPTION INITIATION; VIRION; VIRUS MUTATION; VIRUS REPLICATION; ZINC FINGER MOTIF;

AMINO ACID SEQUENCE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOCAPSID PROTEINS; REVERSE TRANSCRIPTION; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRUS INTEGRATION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 43049089699     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.12.006     Document Type: Article

References (334)

1. Abbink T.E., and Berkhout B. HIV-1 reverse transcription: close encounters between the viral genome and a cellular tRNA. Adv. Pharmacol. 55 (2007) 99-135
2. Accola M.A., Strack B., and Göttlinger H.G. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74 (2000) 5395-5402
3. Akahata W., Ido E., and Hayami M. Mutational analysis of two zinc-finger motifs in the nucleocapsid protein of simian immunodeficiency virus mac239. J. Gen. Virol. 84 (2003) 1641-1648
4. Aldovini A., and Young R.A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64 (1990) 1920-1926
5. Allain B., Lapadat-Tapolsky M., Berlioz C., and Darlix J.L. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J. 13 (1994) 973-981
6. Amarasinghe G.K., De Guzman R.N., Turner R.B., Chancellor K.J., Wu Z.R., and Summers M.F. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J. Mol. Biol. 301 (2000) 491-511
7. Anderson E.C., and Lever A.M. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J. Virol. 80 (2006) 10478-10486
8. Ao Z., Huang G., Yao H., Xu Z., Labine M., Cochrane A.W., and Yao X. Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J. Biol. Chem. 282 (2007) 13456-13467
9. Arhel N.J., Souquere-Besse S., Munier S., Souque P., Guadagnini S., Rutherford S., Prévost M.C., Allen T.D., and Charneau P. HIV-1 DNA flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 26 (2007) 3025-3037
10. Bampi C., Bibillo A., Wendler M., Divita G., Gorelick R.J., Le Grice S.F.J., and Darlix J.-L. Nucleotide excision-repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein. J. Biol. Chem. 281 (2006) 11736-11743
11. Bampi C., Jacquenet S., Lener D., Décimo D., and Darlix J.L. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance. Curr. HIV Res. 2 (2004) 79-92
12. Bampi C., Jacquenet S., Lener D., Décimo D., and Darlix J.L. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance. Int. J. Biochem. Cell Biol. 36 (2004) 1668-1686
13. Barat C., Lullien V., Schatz O., Keith G., Nugeyre M.T., Grüninger-Leitch F., Barré-Sinoussi F., LeGrice S.F., and Darlix J.L. HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 8 (1989) 3279-3285
14. Barat C., Schatz O., Le Grice S., and Darlix J.L. Analysis of the interactions of HIV1 replication primer tRNA(Lys,3) with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 231 (1993) 185-190
15. Barr S.D., Ciuffi A., Leipzig J., Shinn P., Ecker J.R., and Bushman F.D. HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. Mol. Ther. 14 (2006) 218-225
16. Basu, V.P., Song, M., Gao, L., Rigby, S.T., Hanson, M.N., Bambara, R.A., 2008. Strand transfer events during HIV-1 reverse transcription. Virus Res. 134, 19-38.
17. Beerens N., and Berkhout B. In vitro studies on tRNA annealing and reverse transcription with mutant HIV-1 RNA templates. J. Biol. Chem. 275 (2000) 15474-15481
18. Beerens N., and Berkhout B. The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription. J. Virol. 76 (2002) 2329-2339
19. Beerens N., Groot F., and Berkhout B. Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J. Biol. Chem. 276 (2001) 31247-31256
20. Berg J.M. Potential metal-binding domains in nucleic acid binding proteins. Science 232 (1986) 485-487
21. Berkowitz R., Fisher J., and Goff S.P. RNA packaging. Curr. Top. Microbiol. Immunol. 214 (1996) 177-218
22. Berthoux L., Péchoux C., and Darlix J.L. Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication. J. Virol. 73 (1999) 10000-10009
23. Berthoux L., Péchoux C., Ottmann M., Morel G., and Darlix J.L. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis. J. Virol. 71 (1997) 6973-6981
24. Bieth E., Gabus C., and Darlix J.L. A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro. Nucleic Acids Res. 18 (1990) 119-127
25. Boeke J.D., Eichinger D., Castrillon D., and Fink G.R. The Saccharomyces cerevisiae genome contains functional and nonfunctional copies of transposon Ty1. Mol. Cell. Biol. 8 (1988) 1432-1442
26. Booth A.M., Fang Y., Fallon J.K., Yang J.M., Hildreth J.E., and Gould S.J. Exosomes and HIV Gag bud from endosome-like domains of the T-cell plasma membrane. J. Cell Biol. 172 (2006) 923-935
27. Bowerman B., Brown P.O., Bishop J.M., and Varmus H.E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3 (1989) 469-478
28. Bowzard J.B., Bennett R.P., Krishna N.K., Ernst S.M., Rein A., and Wills J.W. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J. Virol. 72 (1998) 9034-9044
29. Brown P.O. Integration. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbor Press, Plainview, NY 161-203
30. Buckman J.S., Bosche W.J., and Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid Zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 77 (2003) 1469-1480
31. Bukrinskaya A.G., Ghorpade A., Heinzinger N.K., Smithgall T.E., Lewis R.E., and Stevenson M. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 367-371
32. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubel A., Spitz L., Lewis P., Goldfarb D., Emerman M., and Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365 (1993) 666-669
33. Bushman F.D. Host proteins in retroviral cDNA integration. Adv. Virus Res. 52 (1999) 301-317
34. Bushman F.D. Integration site selection by lentiviruses: biology and possible control. Curr. Top. Microbiol. Immunol. 261 (2002) 165-177
35. Bushman F.D., and Craigie R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1339-1343
36. Butler S.L., Hansen M.S., and Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7 (2001) 631-634
37. Butsch M., and Boris-Lawrie K. Destiny of unspliced retroviral RNA: ribosome and/or virion?. J. Virol. 76 (2002) 3089-3094
38. Campbell S., and Rein A. In vitro assembly properties of human immunodeficiency virus type 1 gag protein lacking the p6 domain. J. Virol. 73 (1999) 2270-2279
39. Campbell S., and Vogt V.M. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69 (1995) 6487-6497
40. Campbell S., and Vogt V.M. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles. J. Virol. 71 (1997) 4425-4435
41. 2+-dependent DNA integration in vitro. J. Virol. 71 (1997) 6225-6229
42. Carteau S., Gorelick R.J., and Bushman F.D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J. Virol. 73 (1999) 6670-6679
43. Cen S., Huang Y., Khorchid A., Darlix J.L., Wainberg M.A., and Kleiman L. The role of Pr55(gag) in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNA. J. Virol. 73 (1999) 4485-4488
44. Cen S., Javanbakht H., Kim S., Shiba K., Craven R., Rein A., Ewalt K., Schimmel P., Musier-Forsyth K., and Kleiman L. Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs. J. Virol. 76 (2002) 13111-13115
45. Charneau P., Alizon M., and Clavel F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66 (1992) 2814-2820
46. Chen H., and Engelman A. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15270-15274
47. Cimarelli A., and Luban J. Context-dependent phenotype of a human immunodeficiency virus type 1 nucleocapsid mutation. J. Virol. 75 (2001) 7193-7197
48. Cimarelli A., Sandin S., Höglund S., and Luban J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 74 (2000) 3046-3057
49. Cimarelli A., Sandin S., Höglund S., and Luban J. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation. J. Virol. 74 (2000) 4273-4283
50. Coren L.V., Thomas J.A., Chertova E., Sowder II R.C., Gagliardi T.D., Gorelick R.J., and Ott D.E. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1. J. Virol. 81 (2007) 10047-10054
51. Covey S.N. Amino acid sequence homology in gag region of reverse transcribing elements and the coat protein gene of cauliflower mosaic virus. Nucleic Acids Res. 14 (1986) 623-633
52. Crise B., Li Y., Yuan C., Morcock D.R., Whitby D., Munroe D.J., Arthur L.O., and Wu X. Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol. 79 (2005) 12199-12204
53. Cristofari G., Bampi C., Wilhelm M., Wilhelm F.X., and Darlix J.L. A 5′-3′ long-range interaction in Ty1 RNA controls its reverse transcription and retrotransposition. EMBO J. 21 (2002) 4368-4379
54. Cristofari G., Ficheux D., and Darlix J.L. The Gag-like protein of the yeast Ty1 retrotransposon contains a nucleic acid chaperone domain analogous to retroviral nucleocapsid proteins. J. Biol. Chem. 275 (2000) 19210-19217
55. Cristofari G., Gabus C., Ficheux D., Bona M., Le Grice S.F., and Darlix J.L. Characterization of active reverse transcriptase and nucleoprotein complexes of the yeast retrotransposon Ty3 in vitro. J. Biol. Chem. 274 (1999) 36643-36648
56. Cruceanu M., Urbaneja M.A., Hixson C.V., Johnson D.G., Datta S.A., Fivash M.J., Stephen A.G., Fisher R.J., Gorelick R.J., Casas-Finet J.R., Rein A., Rouzina I., and Williams M.C. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res. 34 (2006) 593-605
57. Darlix J.L., Cristofari G., Rau M., Péchoux C., Berthoux L., and Roques B. Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs. Adv. Pharmacol. 48 (2000) 345-372
58. Darlix J.L., Garrido J.L., Morellet N., Mély Y., and de Rocquigny H. Properties, functions, and drug targeting of the multifunctional nucleocapsid protein of the human immunodeficiency virus. Adv. Pharmacol. 55 (2007) 299-346
59. Darlix J.L., Lapadat-Tapolsky M., de Rocquigny H., and Roques B. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254 (1995) 523-537
60. Darlix, J.L., Lastra, M.L., Mély, Y., Roques, B., 2002. Nucleocapsid protein chaperoning of nucleic acids at the heart of HIV structure, assembly and cDNA synthesis. In: Kuiken, C., Foley, B., Freed, E., Hahn, B., Korber, B., Marx, P.A., McCutchan, F., Mellors, J.W., Wolinksy, S. (Eds.), HIV Sequence Compendium 2002. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, LA-UR 03-3564, pp. 71-82.
61. Dawson L., and Yu X.F. The role of nucleocapsid of HIV-1 in virus assembly. Virology 251 (1998) 141-157
62. De Clercq E. New developments in anti-HIV chemotherapy. Biochim. Biophys. Acta 1587 (2002) 258-275
63. De Guzman R.N., Turner R.B., and Summers M.F. Protein-RNA recognition. Biopolymers 48 (1998) 181-195
64. De Guzman R.N., Wu Z.R., Stalling C.C., Pappalardo L., Borer P.N., and Summers M.F. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science 279 (1998) 384-388
65. Deneka M., Pelchen-Matthews A., Byland R., Ruiz-Mateos E., and Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 177 (2007) 329-341
66. De Rijck J., and Debyser Z. The central DNA flap of the human immunodeficiency virus type 1 is important for viral replication. Biochem. Biophys. Res. Commun. 349 (2006) 1100-1110
67. de Rocquigny H., Ficheux D., Gabus C., Fournié-Zaluski M.C., Darlix J.L., and Roques B.P. First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form. Biochem. Biophys. Res. Commun. 31 (1991) 1010-1018
68. de Rocquigny H., Gabus C., Vincent A., Fournié-Zaluski M.C., Roques B., and Darlix J.L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6472-6476
69. de Rocquigny, H., Shvadchak, V., Avilov, S., Dong, C.Z., Dietrich, U., Darlix, J.L., Mély, Y., 2008. Targeting the viral nucleocapsid protein in anti-HIV-1 therapy. MiniRev. Med. Chem. 8, 24-35.
70. Derebail S.S., Heath M.J., and DeStefano J.J. Evidence for the differential effects of nucleocapsid protein on strand transfer in various regions of the HIV genome. J. Biol. Chem. 278 (2003) 15702-15712
71. Derrington E., Gabus C., Leblanc P., Chnaidermann J., Grave L., Dormont D., Swietnicki W., Morillas M., Marck D., Nandi P., and Darlix J.L. PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C.R. Biol. 325 (2002) 17-23
72. Derse D., Hill S.A., Princler G., Lloyd P., and Heidecker G. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in NC. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 2915-2920
73. Dismuke D.J., and Aiken C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J. Virol. 80 (2006) 3712-3720
74. Dobard C.W., Briones M.S., and Chow S.A. Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription. J. Virol. 81 (2007) 10037-10046
75. Dorfman T., Luban J., Goff S.P., Haseltine W.A., and Göttlinger H.G. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67 (1993) 6159-6169
76. Dorman N., and Lever A. Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus. J. Virol. 74 (2000) 11413-11417
77. Driscoll M.D., and Hughes S.H. Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences. J. Virol. 74 (2000) 8785-8792
78. Druillennec S., Dong C.Z., Escaich S., Gresh N., Bousseau A., Roques B.P., and Fournié-Zaluski M.C. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4886-4891
79. Drummond J.E., Mounts P., Gorelick R.J., Casas-Finet J.R., Bosche W.J., Henderson L.E., Waters D.J., and Arthur L.O. Wild-type and mutant HIV type 1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptase. AIDS Res. Hum. Retroviruses 13 (1997) 533-543
80. D'Souza V., and Summers M.F. How retroviruses select their genomes. Nat. Rev. Microbiol. 3 (2005) 643-655
81. Dvorin J.D., Bell P., Maul G.G., Yamashita M., Emerman M., and Malim M.H. Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J. Virol. 76 (2002) 12087-12096
82. Dvorin J.D., and Malim M.H. Intracellular trafficking of HIV-1 cores: journey to the center of the cell. Curr. Top. Microbiol. Immunol. 281 (2003) 179-208
83. Ellis J., and Bernstein A. Retrovirus vectors containing an internal attachment site: evidence that circles are not intermediates to murine retrovirus integration. J. Virol. 63 (1989) 2844-2846
84. Engelman A., Englund G., Orenstein J.M., Martin M.A., and Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69 (1995) 2729-2736
85. Esposito D., and Craigie R. HIV integrase structure and function. Adv. Virus Res. 52 (1999) 319-333
86. Farnet C.M., and Bushman F.D. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88 (1997) 483-492
87. Farnet C.M., and Haseltine W.A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65 (1991) 1910-1915
88. Fassati A., and Goff S.P. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75 (2001) 3626-3635
89. Faure A., Calmels C., Desjobert C., Castroviejo M., Caumont-Sarcos A., Tarrago-Litvak L., Litvak S., and Parissi V. HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res. 33 (2005) 977-986
90. Feng Y.X., Campbell S., Harvin D., Ehresmann B., Ehresmann C., and Rein A. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J. Virol. 73 (1999) 4251-4256
91. Feng Y.X., Copeland T.D., Henderson L.E., Gorelick R.J., Bosche W.J., Levin J.G., and Rein A. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7577-7581
92. Finzi A., Orthwein A., Mercier J., and Cohen E.A. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol. 81 (2007) 7476-7490
93. Fisher R., Fivash M.J., Stephen A.G., Hagan N.A., Shenoy S.R., Medaglia M.V., Smith L.R., Worthy K.M., Simpson J.T., Shoemaker R., McNitt K.L., Johnson D.G., Hixson C.V., Gorelick R.J., Fabris D., Henderson L.E., and Rein A. Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides. Nucleic Acids Res. 34 (2006) 472-484
94. Fisher T.S., Darden T., and Prasad V.R. Substitutions at Phe61 in the β3-β4 hairpin of HIV-1 reverse transcriptase reveal a role for the fingers subdomain in strand displacement DNA synthesis. J. Mol. Biol. 325 (2003) 443-459
95. 2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology 268 (2000) 294-307
96. Forshey B.M., Shi J., and Aiken C. Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in Owl monkey cells. J. Virol. 79 (2005) 869-875
97. Forshey B.M., von Schwedler U., Sundquist W.I., and Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76 (2002) 5667-5677
98. Fouchier R.A., Meyer B.E., Simon J.H., Fischer U., Albright A.V., González-Scarano F., and Malim M.H. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 72 (1998) 6004-6013
99. Fouchier R.A., Meyer B.E., Simon J.H., Fischer U., and Malim M.H. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16 (1997) 4531-4539
100. Freed E.O., Englund G., Maldarelli F., and Martin M.A. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell 88 (1997) 171-173
101. Fu W., Gorelick R.J., and Rein A. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J. Virol. 68 (1994) 5013-5018
102. Fu W., Ortiz-Conde B.A., Gorelick R.J., Hughes S.H., and Rein A. Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses. J. Virol. 71 (1997) 6940-6946
103. Fu W., and Rein A. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67 (1993) 5443-5449
104. Fuentes G.M., Palaniappan C., Fay P.J., and Bambara R.A. Strand displacement synthesis in the central polypurine tract region of HIV-1 promotes DNA to DNA strand transfer recombination. J. Biol. Chem. 271 (1996) 29605-29611
105. Fuentes G.M., Rodriguez-Rodriguez L., Palaniappan C., Fay P.J., and Bambara R.A. Strand displacement synthesis of the long terminal repeats by HIV reverse transcriptase. J. Biol. Chem. 271 (1996) 1966-1971
106. Furuta R.A., Shimano R., Ogasawara T., Inubushi R., Amano K., Akari H., Hatanaka M., Kawamura M., and Adachi A. HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases. FEBS Lett. 415 (1997) 231-234
107. Gabus C., Auxilien S., Péchoux C., Dormont D., Swietnicki W., Morillas M., Surewicz W., Nandi P., and Darlix J.L. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J. Mol. Biol. 307 (2001) 1011-1021
108. Gabus C., Derrington E., Leblanc P., Chnaiderman J., Dormont D., Swietnicki W., Morillas M., Surewicz W.K., Marc D., Nandi P., and Darlix J.L. The prion protein has RNA binding and chaperoning properities characteristic of nucleocapsid protein NCp7 of HIV-1. J. Biol. Chem. 276 (2001) 19301-19309
109. Lys,2 binding sites in the endogenous retrovirus Gypsy. Nucleic Acids Res. 34 (2006) 5764-5777
110. Gallay P., Hope T., Chin D., and Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 9825-9830
111. Gallay P., Swingler S., Aiken C., and Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80 (1995) 379-388
112. Gallay P., Swingler S., Song J., Bushman F., and Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83 (1995) 569-576
113. Ganser B.K., Li S., Klishko V.Y., Finch J.T., and Sundquist W.I. Assembly and analysis of conical models for the HIV-1 core. Science 283 (1999) 80-83
114. Gao K., Butler S.L., and Bushman F. Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO J. 20 (2001) 3565-3576
115. Gao K., Gorelick R.J., Johnson D.G., and Bushman F. Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro. J. Virol. 77 (2003) 1598-1603
116. Girard P.M., Bonnet-Mathonière B., Muriaux D., and Paoletti J. A short autocomplementary sequence in the 5′ leader region is responsible for dimerization of MoMLV genomic RNA. Biochemistry 34 (1995) 9785-9794
117. Goel A., Mazur S.J., Fattah R.J., Hartman T.L., Turpin J.A., Huang M., Rice W.G., Appella E., and Inman J.K. Benzamide-based thiolcarbamates: a new class of HIV-1 NCp7 inhibitors. Bioorg. Med. Chem. Lett. 12 (2002) 767-770
118. Gonsky J., Bacharach E., and Goff S.P. Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo. J. Virol. 75 (2001) 2616-2626
119. Goodarzi G., Pursley M., Felock P., Witmer M., Hazuda D., Brackmann K., and Grandgenett D. Efficiency and fidelity of full-site integration reactions using recombinant simian immunodeficiency virus integrase. J. Virol. 73 (1999) 8104-8111
120. Gorelick R.J., Benveniste R.E., Gagliardi T.D., Wiltrout T.A., Busch L.K., Bosche W.J., Coren L.V., Lifson J.D., Bradley P.J., Henderson L.E., and Arthur L.O. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo. Virology 253 (1999) 259-270
121. Gorelick R.J., Chabot D.J., Ott D.E., Gagliardi T.D., Rein A., Henderson L.E., and Arthur L.O. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 70 (1996) 2593-2597
122. Gorelick R.J., Chabot D.J., Rein A., Henderson L.E., and Arthur L.O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67 (1993) 4027-4036
123. Gorelick R.J., Fu W., Gagliardi T.D., Bosche W.J., Rein A., Henderson L.E., and Arthur L.O. Characterization of the block in replication of nucleocapsid protein zinc finger mutants from Moloney murine leukemia virus. J. Virol. 73 (1999) 8185-8195
124. Gorelick R.J., Gagliardi T.D., Bosche W.J., Wiltrout T.A., Coren L.V., Chabot D.J., Lifson J.D., Henderson L.E., and Arthur L.O. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology 256 (1999) 92-104
125. Gorelick R.J., Henderson L.E., Hanser J.P., and Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 8420-8424
126. Gorelick R.J., Nigida Jr. S.M., Bess Jr. J.W., Arthur L.O., Henderson L.E., and Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64 (1990) 3207-3211
127. Göttlinger H.G., Sodroski J.G., and Haseltine W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5781-5785
128. Graves B.J., Eisenman R.N., and McKnight S.L. Delineation of transcriptional control signals within the Moloney murine sarcoma virus long terminal repeat. Mol. Cell. Biol. 5 (1985) 1948-1958
129. Grigorov B., Décimo D., Smagulova F., Péchoux C., Mougel M., Muriaux D., and Darlix J.L. Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers. Retrovirology 4 (2007) 54
130. Guo J., Henderson L.E., Bess J., Kane B., and Levin J.G. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J. Virol. 71 (1997) 5178-5188
131. Guo J., Wu T., Anderson J., Kane B.F., Johnson D.G., Gorelick R.J., Henderson L.E., and Levin J.G. Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J. Virol. 74 (2000) 8980-8988
132. Guo X., Kameoka M., Wei X., Roques B., Gotte M., Liang C., and Wainberg M.A. Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences. Virology 307 (2003) 154-163
133. Hameau L., Jeusset J., Lafosse S., Coulaud D., Delain E., Unge T., Restle T., Le Cam E., and Mirambeau G. Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement DNA synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein. J. Virol. 75 (2001) 3301-3313
134. Hansen L.J., and Sandmeyer S.B. Characterization of a transpositionally active Ty3 element and identification of the Ty3 integrase protein. J. Virol. 64 (1990) 2599-2607
135. Hargittai M.R., Gorelick R.J., Rouzina I., and Musier-Forsyth K. Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site. J. Mol. Biol. 337 (2004) 951-968
136. Hargittai M.R., Mangla A.T., Gorelick R.J., and Musier-Forsyth K. HIV-1 nucleocapsid protein zinc finger structures induce tRNA(Lys,3) structural changes but are not critical for primer/template annealing. J. Mol. Biol. 312 (2001) 985-997
137. Henderson L.E., Bowers M.A., Sowder II R.C., Serabyn S.A., Johnson D.G., Bess Jr. J.W., Arthur L.O., Bryant D.K., and Fenselau C. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66 (1992) 1856-1865
138. Henderson L.E., Copeland T.D., Sowder R.C., Smythers G.W., and Oroszlan S. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 256 (1981) 8400-8406
139. Henriet S., Sinck L., Bec G., Gorelick R.J., Marquet R., and Paillart J.C. Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription. Nucleic Acids Res. 35 (2007) 5141-5153
140. Hindmarsh P., and Leis J. Retroviral DNA integration. Microbiol. Mol. Biol. Rev. 63 (1999) 836-843
141. Hombrouck A., De Rijck J., Hendrix J., Vandekerckhove L., Voet A., De Maeyer M., Witvrouw M., Engelborghs Y., Christ F., Gijsbers R., and Debyser Z. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog. 3 (2007) e47
142. Hu W.S., and Temin H.M. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1556-1560
143. Hu W.S., and Temin H.M. Retroviral recombination and reverse transcription. Science 250 (1990) 1227-1233
144. Huang Y., Khorchid A., Gabor J., Wang J., Li X., Darlix J.L., Wainberg M.A., and Kleiman L. The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1. J. Virol. 72 (1998) 3907-3915
145. Ivanov D., Stone J.R., Maki J.L., Collins T., and Wagner G. Mammalian SCAN domain dimer is a domain-swapped homolog of the HIV capsid C-terminal domain. Mol. Cell 17 (2005) 137-143
146. Jeanson L., and Mouscadet J.F. Ku represses the HIV-1 transcription: identification of a putative Ku binding site homologous to the mouse mammary tumor virus NRE1 sequence in the HIV-1 long terminal repeat. J. Biol. Chem. 277 (2002) 4918-4924
147. Jeanson L., Subra F., Vaganay S., Hervy M., Marangoni E., Bourhis J., and Mouscadet J.F. Effect of Ku80 depletion on the preintegrative steps of HIV-1 replication in human cells. Virology 300 (2002) 100-108
148. Jeeninga R.E., Huthoff H.T., Gultyaev A.P., and Berkhout B. The mechanism of actinomycin D-mediated inhibition of HIV-1 reverse transcription. Nucleic Acids Res. 26 (1998) 5472-5479
149. Jentoft J.E., Smith L.M., Fu X.D., Johnson M., and Leis J. Conserved cysteine and histidine residues of the avian myeloblastosis virus nucleocapsid protein are essential for viral replication but are not "zinc-binding fingers". Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 7094-7098
150. Ji X., Klarmann G.J., and Preston B.D. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 35 (1996) 132-143
151. Johnson M.C., Scobie H.M., Ma Y.M., and Vogt V.M. Nucleic acid-independent retrovirus assembly can be driven by dimerization. J. Virol. 76 (2002) 11177-11185
152. Johnson P.E., Turner R.B., Wu Z.R., Hairston L., Guo J., Levin J.G., and Summers M.F. A mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid protein during reverse transcription. Biochemistry 39 (2000) 9084-9091
153. Jolly C., Mitar I., and Sattentau Q.J. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J. Virol. 81 (2006) 5547-5560
154. Jolly C., and Sattentau Q.J. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol. 81 (2007) 7873-7884
155. Jones K.S., Coleman J., Merkel G.W., Laue T.M., and Skalka A.M. Retroviral integrase functions as a multimer and can turn over catalytically. J. Biol. Chem. 267 (1992) 16037-16040
156. Jouve M., Sol-Foulon N., Watson S., Schwartz O., and Benaroch P. HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host Microbe 2 (2007) 85-95
157. Jouvenet N., Neil S.J., Bess C., Johnson M.C., Virgen C.A., Simon S.M., and Bieniasz P.D. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4 (2006) e435
158. Kankia B.I., Barany G., and Musier-Forsyth K. Unfolding of DNA quadruplexes induced by HIV-1 nucleocapsid protein. Nucleic Acids Res. 33 (2005) 4395-4403
159. Kaplan A.H., Krogstad P., Kempf D.J., Norbeck D.W., and Swanstrom R. Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA. Antimicrob. Agents Chemother. 38 (1994) 2929-2933
160. Kaplan A.H., Manchester M., and Swanstrom R. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 68 (1994) 6782-6786
161. Kaplan A.H., Zack J.A., Knigge M., Paul D.A., Kempf D.J., Norbeck D.W., and Swanstrom R. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67 (1993) 4050-4055
162. Katz R.A., Merkel G., Kulkosky J., Leis J., and Skalka A.M. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63 (1990) 87-95
163. Kaushik R., and Ratner L. Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication. J. Virol. 78 (2004) 2319-2326
164. Kawamura M., Shimano R., Inubushi R., Akari H., and Adachi A. Early function of HIV-1 Gag proteins is cell-dependent. Biochem. Biophys. Res. Commun. 248 (1998) 899-903
165. Kelleher C.D., and Champoux J.J. Characterization of RNA strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase. J. Biol. Chem. 273 (1998) 9976-9986
166. Khan R., and Giedroc D.P. Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 267 (1992) 6689-6695
167. Khan R., and Giedroc D.P. Nucleic acid binding properties of recombinant Zn2 HIV-1 nucleocapsid protein are modulated by COOH-terminal processing. J. Biol. Chem. 269 (1994) 22538-22546
168. Kiernan R.E., Ono A., Englund G., and Freed E.O. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72 (1998) 4116-4126
169. Kilzer J.M., Stracker T., Beitzel B., Meek K., Weitzman M., and Bushman F.D. Roles of host cell factors in circularization of retroviral DNA. Virology 314 (2003) 460-467
170. Kirchner J., and Sandmeyer S. Proteolytic processing of Ty3 proteins is required for transposition. J. Virol. 67 (1993) 19-28
171. Klasens B.I., Huthoff H.T., Das A.T., Jeeninga R.E., and Berkhout B. The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim. Biophys. Acta 1444 (1999) 355-370
172. Koh K., Miyaura M., Yoshida A., Sakurai A., Fujita M., and Adachi A. Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells. Microbes Infect. 2 (2000) 1419-1423
173. Kräusslich H.G. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3213-3217
174. Kräusslich H.G., Fäcke M., Heuser A.M., Konvalinka J., and Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69 (1995) 3407-3419
175. Krishnamoorthy G., Roques B., Darlix J.L., and Mély Y. DNA condensation by the nucleocapsid protein of HIV-1: a mechanism ensuring DNA protection. Nucleic Acids Res. 31 (2003) 5425-5432
176. Laimins L.A., Tsichlis P.N., and Khoury G. Multiple enhancer domains in the 3′ terminus of the Prague strain of Rous sarcoma virus. Nucleic Acids Res. 12 (1984) 6427-6442
177. Lapadat-Tapolsky M., de Rocquigny H., Van Gent D., Roques B., Plasterk R., and Darlix J.L. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21 (1993) 831-839
178. Lapadat-Tapolsky M., Gabus C., Rau M., and Darlix J.L. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 268 (1997) 250-260
179. Laughrea M., Shen N., Jetté L., Darlix J.L., Kleiman L., and Wainberg M.A. Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin. Virology 281 (2001) 109-116
180. Lee B.M., De Guzman R.N., Turner B.G., Tjandra N., and Summers M.F. Dynamical behavior of the HIV-1 nucleocapsid protein. J. Mol. Biol. 12 (1998) 633-649
181. Lee E.G., and Linial M.L. Basic residues of the retroviral nucleocapsid play different roles in gag-gag and Gag-Psi RNA interactions. J. Virol. 78 (2004) 8486-8495
182. Lee E.G., and Linial M.L. Deletion of a Cys-His motif from the Alpharetrovirus nucleocapsid domain reveals late domain mutant-like budding defects. Virology 347 (2006) 226-233
183. Leis J., Baltimore D., Bishop J.M., Coffin J., Fleissner E., Goff S.P., Oroszlan S., Robinson H., Skalka A.M., Temin H.M., and Vogt V. Standardized and simplified nomenclature for proteins common to all retroviruses. J. Virol. 62 (1988) 1808-1809
184. Leitner, T., Foley, B., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinksy, S., Korber, B. (Eds.), 2007. HIV sequence compendium 2006/2007. In: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, LA-UR 07-7826, Los Alamos, NM.
185. Lener D., Tanchou V., Roques B.P., Le Grice S.F., and Darlix J.L. Involvement of HIV-1 nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J. Biol. Chem. 273 (1998) 33781-33786
186. Levin J.G., Guo J., Rouzina I., and Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog. Nucleic Acid Res. Mol. Biol. 80 (2005) 217-286
187. Li F., Goila-Gaur R., Salzwedel K., Kilgore N.R., Reddick M., Matallana C., Castillo A., Zoumplis D., Martin D.E., Orenstein J.M., Allaway G.P., Freed E.O., and Wild C.T. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13555-13560
188. Li H., Dou J., Ding L., and Spearman P. Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells. J. Virol. 81 (2007) 12899-12910
189. Li L., Olvera J.M., Yoder K.E., Mitchell R.S., Butler S.L., Lieber M., Martin S.L., and Bushman F.D. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20 (2001) 3272-3281
190. Li M., Mizuuchi M., Burke T.R., and Craigie R. Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J. 25 (2006) 1295-1304
191. Limón A., Devroe E., Lu R., Ghory H.Z., Silver P.A., and Engelman A. Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J. Virol. 76 (2002) 10598-10607
192. Limón A., Nakajima N., Lu R., Ghory H.Z., and Engelman A. Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap. J. Virol. 76 (2002) 12078-12086
193. Linial M.L. Foamy viruses are unconventional retroviruses. J. Virol. 73 (1999) 1747-1755
194. Lobel L.I., Murphy J.E., and Goff S.P. The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J. Virol. 63 (1989) 2629-2637
195. Lori F., di Marzo Veronese F., de Vico A.L., Lusso P., Reitz Jr. M.S., and Gallo R.C. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66 (1992) 5067-5074
196. Lyonnais S., Gorelick R.J., Mergny J.L., Le Cam E., and Mirambeau G. G-quartets direct assembly of HIV-1 nucleocapsid protein along single-stranded DNA. Nucleic Acids Res. 31 (2003) 5754-5763
197. Lyonnais S., Hounsou C., Teulade-Fichou M.P., Jeusset J., Le Cam E., and Mirambeau G. G-quartets assembly within a G-rich DNA flap. A possible event at the center of the HIV-1 genome. Nucleic Acids Res. 30 (2002) 5276-5283
198. Manrique M.L., Rauddi M.L., González S.A., and Affranchino J.L. Functional domains in the feline immunodeficiency virus NC protein. Virology 327 (2004) 83-92
199. Marlor R.L., Parkhurst S.M., and Corces V.G. The Drosophila melanogaster gypsy transposable element encodes putative gene products homologous to retroviral proteins. Mol. Cell. Biol. 6 (1986) 1129-1134
200. Marquet R., Isel C., Ehresmann C., and Ehresmann B. tRNAs as primer of reverse transcriptases. Biochimie 77 (1995) 113-124
201. Marsden M.D., and Zack J.A. Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo. J. Virol. 81 (2007) 6146-6150
202. Masuda T., Planelles V., Krogstad P., and Chen I.S. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69 (1995) 6687-6696
203. Méric C., and Goff S.P. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63 (1989) 1558-1568
204. Méric C., Gouilloud E., and Spahr P.F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes. J. Virol. 62 (1988) 3328-3333
205. Méric C., and Spahr P.F. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 60 (1986) 450-459
206. Merkulov G.V., Swiderek K.M., Brachmann C.B., and Boeke J.D. A critical proteolytic cleavage site near the C terminus of the yeast retrotransposon Ty1 Gag protein. J. Virol. 70 (1996) 5548-5556
207. Miller M.D., Farnet C.M., and Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71 (1997) 5382-5390
208. Miller Jenkins L.M., Hara T., Durell S.R., Hayashi R., Inman J.K., Piquemal J.P., Gresh N., and Appella E. Specificity of acyl transfer from 2-mercaptobenzamide thioesters to the HIV-1 nucleocapsid protein. J. Am. Chem. Soc. 129 (2007) 11067-11078
209. Mirambeau G., Lyonnais S., Coulaud D., Hameau L., Lafosse S., Jeusset J., Borde I., Reboud-Ravaux M., Restle T., Gorelick R.J., and Le Cam E. HIV-1 protease and reverse transcriptase control the architecture of their nuclecapsid partner. PLoS One 2 (2007) e669
210. Mirambeau G., Lyonnais S., Coulaud D., Hameau L., Lafosse S., Jeusset J., Justome A., Delain E., Gorelick R.J., and Le Cam E. Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein. J. Mol. Biol. 364 (2006) 496-511
211. Mitchell R.S., Beitzel B.F., Schröder A.R., Shinn P., Chen H., Berry C.C., Ecker J.R., and Bushman F.D. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2 (2004) e234
212. Mizuno A., Ido E., Goto T., Kuwata T., Nakai M., and Hayami M. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: effects on proteolytic processing of Gag precursors and particle formation. AIDS Res. Hum. Retroviruses 12 (1996) 793-800
213. Morcock D.R., Thomas J.A., Gagliardi T.D., Gorelick R.J., Roser J.D., Chertova E.N., Bess Jr. J.W., Ott D.E., Sattentau Q.J., Frank I., Pope M., Lifson J.D., Henderson L.E., and Crise B.J. Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins. J. Virol. 79 (2005) 1533-1542
214. 1H NMR. J. Mol. Biol. 7 (1994) 287-301
215. 1H NMR. EMBO J. 11 (1992) 3059-3065
216. Mount S.M., and Rubin G.M. Complete nucleotide sequence of the Drosophila transposable element copia: homology between copia and retroviral proteins. Mol. Cell Biol. 5 (1985) 1630-1638
217. Muriaux D., Costes S., Nagashima K., Mirro J., Cho E., Lockett S., and Rein A. Role of murine leukemia virus nucleocapsid protein in virus assembly. J. Virol. 78 (2004) 12378-12385
218. Muriaux D., de Rocquigny H., Roques B.P., and Paoletti J. NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer. J. Biol. Chem. 271 (1996) 33686-33692
219. Muriaux D., Mirro J., Harvin D., and Rein A. RNA is a structural element in retrovirus particles. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5246-5251
220. Muriaux D., Mirro J., Nagashima K., Harvin D., and Rein A. Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes. J. Virol. 76 (2002) 11405-11413
221. Nagy K., Young M., Baboonian C., Merson J., Whittle P., and Oroszlan S. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase. J. Virol. 68 (1994) 757-765
222. Narezkina A., Taganov K.D., Litwin S., Stoyanova R., Hayashi J., Seeger C., Skalka A.M., and Katz R.A. Genome-wide analyses of avian sarcoma virus integration sites. J. Virol. 78 (2004) 11656-11663
223. Negroni M., and Buc H. Recombination during reverse transcription: an evaluation of the role of the nucleocapsid protein. J. Mol. Biol. 286 (1999) 15-31
224. Neil S., Martin F., Ikeda Y., and Collins M. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J. Virol. 75 (2001) 5448-5456
225. Nermut M.V., and Fassati A. Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J. Virol. 77 (2003) 8196-8206
226. Nikolaitchik O., Rhodes T.D., Ott D., and Hu W.S. Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination. J. Virol. 80 (2006) 4691-4697
227. Nisole S., and Saïb A. Early steps of retrovirus replicative cycle. Retrovirology 1 (2004) 9
228. Nydegger S., Foti M., Derdowski A., Spearman P., and Thali M. HIV-1 egress is gated through late endosomal membranes. Traffic 4 (2003) 902-910
229. O'Brien W.A., Namazi A., Kalhor H., Mao S.H., Zack J.A., and Chen I.S. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68 (1994) 1258-1263
230. Ott D.E., Coren L.V., Chertova E.N., Gagliardi T.D., Nagashima K., Sowder II R.C., Poon D.T., and Gorelick R.J. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant. J. Virol. 77 (2003) 5547-5556
231. Ott D.E., Coren L.V., and Gagliardi T.D. Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly. J. Virol. 79 (2005) 13839-13847
232. Ottmann M., Gabus C., and Darlix J.L. The central globular domain of the NC protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 69 (1995) 1778-1784
233. Paulson B.A., Zhang M., Schultz S.J., and Champoux J.J. Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo. Virology 366 (2007) 361-376
234. Peliska J.A., Balasubramanian S., Giedroc D.P., and Benkovic S.J. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 33 (1994) 13817-13823
235. Peliska J.A., and Benkovic S.J. Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258 (1992) 1112-1118
236. Perlman M., and Resh M.D. Identification of an intracellular trafficking and assembly pathway for HIV-1 Gag. Traffic 7 (2006) 731-745
237. Petit C., Schwartz O., and Mammano F. The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. J. Virol. 74 (2000) 7119-7126
238. Pettit S.C., Moody M.D., Wehbie R.S., Kaplan A.H., Nantermet P.V., Klein C.A., and Swanstrom R. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68 (1994) 8017-8027
239. Pettit S.C., Sheng N., Tritch R., Erickson-Viitanen S., and Swanstrom R. The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv. Exp. Med. Biol. 436 (1998) 15-25
240. Pettit S.C., Simsic J., Loeb D.D., Everitt L., Hutchison III C.A., and Swanstrom R. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 266 (1991) 14539-14547
241. Polge E., Darlix J.L., Paoletti J., and Fossé P. Characterization of loose and tight dimer forms of avian leukosis virus RNA. J. Mol. Biol. 300 (2000) 41-56
242. Poljak L., Batson S.M., Ficheux D., Roques B.P., Darlix J.L., and Käs E. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins. J. Mol. Biol. 329 (2003) 411-421
243. Poon D.T., Chertova E.N., and Ott D.E. Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging. Virology 293 (2002) 368-378
244. Poon D.T., Li G., and Aldovini A. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging. J. Virol. 72 (1998) 1983-1993
245. Poon D.T., Wu J., and Aldovini A. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 70 (1996) 6607-6616
246. Prats A.C., Housset V., de Billy G., Cornille F., Prats H., Roques B., and Darlix J.L. Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent. Nucleic Acids Res. 11 (1991) 3533-3541
247. Prats A.C., Sarih L., Gabus C., Litvak S., Keith G., and Darlix J.L. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 7 (1988) 1777-1783
248. Raja A., and DeStefano J.J. Kinetic analysis of the effect of HIV nucleocapsid protein (NCp) on internal strand transfer reactions. Biochemistry 38 (1999) 5178-5184
249. Raja C., Ferner J., Dietrich U., Avilov S., Ficheux D., Darlix J.L., de Rocquigny H., Schwalbe H., and Mély Y. A tryptophan-rich hexapeptide inhibits nucleic acid destabilization chaperoned by the HIV-1 nucleocapsid protein. Biochemistry 45 (2006) 9254-9265
250. Ramirez, B.C., Simon-Loriere, E., Galetto, R., Negroni, M., 2008. Implications of recombination for HIV diversity. Virus Res. 134, 64-73.
251. Rascle J.B., Ficheux D., and Darlix J.L. Possible roles of nucleocapsid protein of MoMuLV in the specificity of proviral DNA synthesis and in the genetic variability of the virus. J. Mol. Biol. 280 (1998) 215-225
252. Rausch J.W., and Le Grice S.F. 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int. J. Biochem. Cell Biol. 36 (2004) 1752-1766
253. Reil H., Bukovsky A.A., Gelderblom H.R., and Göttlinger H.G. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17 (1998) 2699-2708
254. Rein A., Harvin D.P., Mirro J., Ernst S.M., and Gorelick R.J. Evidence that a central domain of NC protein is required for RNA packaging in murine leukemia virus. J. Virol. 68 (1994) 6124-6129
255. Rein A., Henderson L.E., and Levin J.G. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 23 (1998) 297-301
256. Risco C., Menéndez-Arias L., Copeland T.D., Pinto da Silva P., and Oroszlan S. Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. J. Cell Sci. 108 (1995) 3039-3050
257. Roda R.H., Balakrishnan M., Hanson M.N., Wöhrl B.M., Le Grice S.F., Roques B.P., Gorelick R.J., and Bambara R.A. Role of the reverse transcriptase, nucleocapsid protein, and template structure in the two-step transfer mechanism in retroviral recombination. J. Biol. Chem. 278 (2003) 31536-31546
258. Roda R.H., Balakrishnan M., Kim J.K., Roques B.P., Fay P.J., and Bambara R.A. Strand transfer occurs in retroviruses by a pause-initiated two-step mechanism. J. Biol. Chem. 277 (2002) 46900-46911
259. Roe T., Reynolds T.C., Yu G., and Brown P.O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12 (1993) 2099-2108
260. Roebuck K.A., and Saifuddin M. Regulation of HIV-1 transcription. Gene Expr. 8 (1999) 67-84
261. Rong L., Liang C., Hsu M., Guo X., Roques B.P., and Wainberg M.A. HIV-1 nucleocapsid protein and the secondary structure of the binary complex formed between tRNA(Lys,3) and viral RNA template play different roles during initiation of (-) strand DNA reverse transcription. J. Biol. Chem. 276 (2001) 47725-47732
262. Rossio J.L., Esser M.T., Suryanarayana K., Schneider D.K., Bess Jr. J.W., Vasquez G.M., Wiltrout T.A., Chertova E., Grimes M.K., Sattentau Q., Arthur L.O., Henderson L.E., and Lifson J.D. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72 (1998) 7992-8001
263. Rudner L., Nydegger S., Coren L.V., Nagashima K., Thali M., and Ott D.E. Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling. J. Virol. 79 (2005) 4055-4065
264. Rulli Jr. S.J., Hibbert C.S., Mirro J., Pederson T., Biswal S., and Rein A. Selective and nonselective packaging of cellular RNAs in retrovirus particles. J. Virol. 81 (2007) 6623-6631
265. Sandefur S., Smith R.M., Varthakavi V., and Spearman P. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J. Virol. 74 (2000) 7238-7249
266. Gag. J. Virol. 72 (1998) 2723-2732
267. Schröder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F. HIV-1 integration in the human genome favors active genes and local hot spots. Cell 110 (2002) 521-529
268. Schultz, S.J., Champoux, J.J., 2008. RNase H activity: structure, specificity, and function in reverse transcription. Virus Res. 134, 86-103.
269. Shehu-Xhilaga M., Crowe S.M., and Mak J. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J. Virol. 75 (2001) 1834-1841
270. Shehu-Xhilaga M., Kräusslich H.G., Pettit S., Swanstrom R., Lee J.Y., Marshall J.A., Crowe S.M., and Mak J. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J. Virol. 75 (2001) 9156-9164
271. NC-RNA interaction that affect enhanced cleavage by the viral protease. J. Virol. 71 (1997) 5723-5732
272. Sherer N.M., Lehmann M.J., Jimenez-Soto L.F., Ingmundson A., Horner S.M., Cicchetti G., Allen P.G., Pypaert M., Cunningham J.M., and Mothes W. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4 (2003) 785-801
273. Sinha S., and Grandgenett D.P. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells. J. Virol. 79 (2005) 8208-8216
274. Song R., Kafaie J., Yang L., and Laughrea M. HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization. J. Mol. Biol. 371 (2007) 1084-1098
275. South T.L., and Summers M.F. Zinc fingers. In: Marzilli L.G., and Eichorn G. (Eds). Metal Ion-induced Regulation of Gene Expression vol. 8 (1990), Elsevier, New York 199-248
276. Srivastava P., Schito M., Fattah R.J., Hara T., Hartman T., Buckheit Jr. R.W., Turpin J.A., Inman J.K., and Appella E. Optimization of unique, uncharged thioesters as inhibitors of HIV replication. Bioorg. Med. Chem. 12 (2004) 6437-6450
277. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 (2004) 848-853
278. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., and Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 5514-5519
279. Swanstrom R., and Wills J.W. Synthesis, assembly, and processing of viral proteins. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbor Press, Plainview, NY 263-334
280. Takahashi K., Baba S., Koyanagi Y., Yamamoto N., Takaku H., and Kawai G. Two basic regions of NCp7 are sufficient for conformational conversion of HIV-1 dimerization initiation site from kissing-loop dimer to extended-duplex dimer. J. Biol. Chem. 276 (2001) 31274-31278
281. Tanchou V., Décimo D., Péchoux C., Lener D., Rogemond V., Berthoux L., Ottmann M., and Darlix J.L. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J. Virol. 72 (1998) 4442-4447
282. Tanchou V., Gabus C., Rogemond V., and Darlix J.L. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. J. Mol. Biol. 252 (1995) 563-571
283. Tang S., Murakami T., Agresta B.E., Campbell S., Freed E.O., and Levin J.G. Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J. Virol. 75 (2001) 9357-9366
284. Telesnitsky A., and Goff S.P. Reverse transcriptase and the generation of retroviral DNA. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbor Press, Plainview, NY 121-160
285. Thomas D.C., Voronin Y.A., Nikolenko G.N., Chen J., Hu W.-S., and Pathak V.K. Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis. J. Virol. 81 (2007) 4798-4807
286. Thomas J.A., Gagliardi T.D., Alvord W.G., Lubomirski M., Bosche W.J., and Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology 353 (2006) 41-51
287. Thomas J.A., Ott D.E., and Gorelick R.J. Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions. J. Virol. 81 (2007) 4367-4370
288. Thomas J.A., Shulenin S., Coren L.V., Bosche W.J., Gagliardi T.D., Gorelick R.J., and Oroszlan S. Characterization of human immunodeficiency virus type 1 (HIV-1) containing mutations in the nucleocapsid protein at a putative HIV-1 protease cleavage site. Virology 354 (2006) 261-270
289. Tisné C. Structural bases of the annealing of primer tRNA(3Lys) to the HIV-1 viral RNA. Curr. HIV Res. 3 (2005) 147-156
290. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66 (1992) 4893-4900
291. Trono D., and Gallay P. In response to Freed et al. Cell 88 (1997) 173-174
292. Tsuchihashi Z., and Brown P.O. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68 (1994) 5863-5870
293. Turelli P., Doucas V., Craig E., Mangeat B., Klages N., Evans R., Kalpana G., and Trono D. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7 (2001) 1245-1254
294. Turner B.G., and Summers M.F. Structural biology of HIV. J. Mol. Biol. 285 (1999) 1-32
295. Turpin J.A., Song Y., Inman J.K., Huang M., Wallqvist A., Maynard A., Covell D.G., Rice W.G., and Appella E. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J. Med. Chem. 42 (1999) 67-86
296. Urbaneja M.A., Kane B.P., Johnson D.G., Gorelick R.J., Henderson L.E., and Casas-Finet J.R. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function. J. Mol. Biol. 287 (1999) 59-75
297. Urbaneja M.A., Wu M., Casas-Finet J.R., and Karpel R.L. HIV-1 nucleocapsid protein as a nucleic acid chaperone: spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity. J. Mol. Biol. 318 (2002) 749-764
298. Van Maele B., De Rijck J., De Clercq E., and Debyser Z. Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction. J. Virol. 77 (2003) 4685-4694
299. In: van Regenmortel M.H.V., Fauquet C.M., Bishop D.H.L., Carstens E.B., Estes M.K., Lemon S.M., Maniloff J., Mayo M.A., McGeoch D.J., Pringle C.R., and Wickner R.B. (Eds). Virus Taxonomy Classification and Nomenclature of Viruses: Seventh Report of the International Committee on Taxonomy of Viruses (2000), Academic Press, San Diego
300. Vink C., van Gent D.C., Elgersma Y., and Plasterk R.H. Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J. Virol. 65 (1991) 4636-4644
301. von Schwedler U., Kornbluth R.S., and Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6992-6996
302. Vora A., and Grandgenett D.P. DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro. J. Virol. 75 (2001) 3556-3567
303. Wacharapornin P., Lauhakirti D., and Auewarakul P. The effect of capsid mutations on HIV-1 uncoating. Virology 358 (2006) 48-54
304. Wang C.T., and Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67 (1993) 4264-4273
305. Wang S.W., Noonan K., and Aldovini A. Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses. J. Virol. 78 (2004) 716-723
306. Warrilow D., and Harrich D. HIV-1 replication from after cell entry to the nuclear periphery. Curr. HIV Res. 5 (2007) 293-299
307. Waters L.C., and Mullin B.C. Transfer RNA into RNA tumor viruses. Prog. Nucleic Acid Res. Mol. Biol. 20 (1977) 131-160
308. Wei S.Q., Mizuuchi K., and Craigie R. A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J. 16 (1997) 7511-7520
309. Welker R., Hohenberg H., Tessmer U., Huckhagel C., and Kräusslich H.G. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J. Virol. 74 (2000) 1168-1177
310. Welsch S., Keppler O.T., Habermann A., Allespach I., Krijnse-Locker J., and Kräusslich H.G. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3 (2007) e36
311. Whiting S.H., and Champoux J.J. Properties of strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase: mechanistic implications. J. Mol. Biol. 278 (1998) 559-577
312. Wiegers K., Rutter G., Kottler H., Tessmer U., Hohenberg H., and Kräusslich H.G. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72 (1998) 2846-2854
313. Wu T., Guo J., Bess J., Henderson L.E., and Levin J.G. Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems. J. Virol. 73 (1999) 4794-4805
314. Wu T., Heilman-Miller S.L., and Levin J.G. Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein. Nucleic Acids Res. 35 (2007) 3974-3987
315. Wu W., Henderson L.E., Copeland T.D., Gorelick R.J., Bosche W.J., Rein A., and Levin J.G. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 70 (1996) 7132-7142
316. Wu X., Li Y., Crise B., and Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300 (2003) 1749-1751
317. Yamashita M., and Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 78 (2004) 5670-5678
318. Yamashita M., and Emerman M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog. 1 (2005) e18
319. Yamashita M., and Emerman M. Retroviral infection of non-dividing cells: old and new perspectives. Virology 344 (2006) 88-93
320. Yoder K.E., and Bushman F.D. Repair of gaps in retroviral DNA integration intermediates. J. Virol. 74 (2000) 11191-11200
321. You J.C., and McHenry C.S. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269 (1994) 31491-31495
322. Yu Q., and Darlix J.L. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo. J. Virol. 70 (1996) 5791-5798
323. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., and Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61 (1990) 213-222
324. Zack J.A., Haislip A.M., Krogstad P., and Chen I.S. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66 (1992) 1717-1725
325. Zennou V., Petit C., Guetard D., Nerhbass U., Montagnier L., and Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101 (2000) 173-185
326. Zennou V., Serguera C., Sarkis C., Colin P., Perret E., Mallet J., and Charneau P. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19 (2001) 446-450
327. Zhang H., Dornadula G., Orenstein J., and Pomerantz R.J. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core. J. Hum. Virol. 3 (2000) 165-172
328. Zhang H., Zhang Y., Spicer T.P., Abbott L.Z., Abbott M., and Poiesz B.J. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res. Hum. Retroviruses 9 (1993) 1287-1296
329. Zhang J., and Crumpacker C.S. Human immunodeficiency virus type 1 nucleocapsid protein nuclear localization mediates early viral mRNA expression. J. Virol. 76 (2002) 10444-10454
330. Zhang J.L., Sharma P.L., and Crumpacker C.S. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein. Virology 268 (2000) 251-263
331. Zhang W.H., Hwang C.K., Hu W.S., Gorelick R.J., and Pathak V.K. Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo. J. Virol. 76 (2002) 7473-7484
332. Zhang Y., and Barklis E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69 (1995) 5716-5722
333. Zhang Y., Qian H., Love Z., and Barklis E. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J. Virol. 72 (1998) 1782-1789
334. Zhao L.J., Mukherjee S., and Narayan O. Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. J. Biol. Chem. 269 (1994) 15577-15582